These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21217191)

  • 1. Pooled human immunoglobulin therapy in critically Ill patients with pandemic 2009 influenza A(H1N1) pneumonitis and immunoglobulin G2 subclass (IgG2) deficiency.
    Gordon CL; Langan K; Charles PG; Bellomo R; Hart GK; Torresi J; Johnson PD; Grayson ML
    Clin Infect Dis; 2011 Feb; 52(3):422-6. PubMed ID: 21217191
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus.
    Härter G; Zimmermann O; Maier L; Schubert A; Mertens T; Kern P; Wöhrle J
    Clin Infect Dis; 2010 May; 50(9):1249-51. PubMed ID: 20367227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.
    Rodríguez A; Díaz E; Martín-Loeches I; Sandiumenge A; Canadell L; Díaz JJ; Figueira JC; Marques A; Alvarez-Lerma F; Vallés J; Baladín B; García-López F; Suberviola B; Zaragoza R; Trefler S; Bonastre J; Blanquer J; Rello J;
    J Antimicrob Chemother; 2011 May; 66(5):1140-9. PubMed ID: 21385717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful salvage therapy with inhaled zanamivir in a patient with peramivir-resistant pandemic influenza A (H1N1) 2009 virus.
    Park KH; Lee SO; Choi SH; Kim MN; Lee JH; Yi H; Kim MS; Hong EH; Kim YS; Woo JH; Kim SH
    Scand J Infect Dis; 2011 Feb; 43(2):151-5. PubMed ID: 20854216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G.
    Chong JL; Sapari S; Kuan YC
    J Microbiol Immunol Infect; 2011 Aug; 44(4):319-22. PubMed ID: 21524955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mortality in critically ill patients infected with 2009 pandemic influenza A (H1N1) with pneumonia and acute kidney injury.
    Kute VB; Godara SM; Goplani KR; Gumber MR; Shah PR; Vanikar AV; Shah VR; Trivedi HL
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):83-9. PubMed ID: 21196619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
    Aardema H; Tulleken JE; van den Biggelaar RJ; Wolters BA; de Jager CM; Boucher CA; Riezebos-Brilman A
    Ned Tijdschr Geneeskd; 2010; 154():A1634. PubMed ID: 20482913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of a Dutch cohort of critically ill children due to the 2009 new influenza A H1N1 pandemic.
    van Zwol A; Witteveen R; Markhorst D; Geukers VG
    Clin Pediatr (Phila); 2011 Jan; 50(1):69-72. PubMed ID: 20837610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe myopathy caused by the new pandemic influenza A (H1N1) in a child.
    Dinler G; Sensoy G; Sungur M; Asilioğlu N; Taşdemir HA; Kalayci AG
    Trop Doct; 2010 Oct; 40(4):242-3. PubMed ID: 20643868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe H1N1 infection in a pediatric liver transplant recipient treated with intravenous zanamivir: efficiency and complications.
    Dohna-Schwake C; Schweiger B; Felderhoff-Müser U; Fiedler M; Kaiser GM; Paul A; Gerner P; Lainka E; Hoyer PF
    Transplantation; 2010 Jul; 90(2):223-4. PubMed ID: 20644456
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of pandemic (H1N1) 2009 virus infection among healthcare workers caring for critically ill patients with pandemic (H1N1) 2009 virus infection.
    Moorthy M; Chacko B; Ramakrishna K; Samuel P; Karthik G; Kalki RC; Abraham AM; Akhuj A; Valsan A; Abraham OC; Peter JV
    J Hosp Infect; 2011 Apr; 77(4):365-6. PubMed ID: 21316801
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus.
    Medeiros R; Rameix-Welti MA; Lorin V; Ribaud P; Manuguerra JC; Socie G; Scieux C; Naffakh N; van der Werf S
    Antivir Ther; 2007; 12(4):571-6. PubMed ID: 17668567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency.
    Gordon CL; Johnson PD; Permezel M; Holmes NE; Gutteridge G; McDonald CF; Eisen DP; Stewardson AJ; Edington J; Charles PG; Crinis N; Black MJ; Torresi J; Grayson ML
    Clin Infect Dis; 2010 Mar; 50(5):672-8. PubMed ID: 20121412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1).
    Louie JK; Acosta M; Samuel MC; Schechter R; Vugia DJ; Harriman K; Matyas BT;
    Clin Infect Dis; 2011 Feb; 52(3):301-12. PubMed ID: 21208911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute chest syndrome in sickle cell disease due to the new influenza A (H1N1) virus infection.
    van Tuijn CF; Nur E; van Beers EJ; Zaaijer HL; Biemond BJ
    Am J Hematol; 2010 Apr; 85(4):303-4. PubMed ID: 20169545
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
    [No Abstract]   [Full Text] [Related]  

  • 18. A close-up view of flu.
    Kung YM
    Nurse Pract; 2010 Apr; 35(4):47-52. PubMed ID: 20299912
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
    Duwe SC; Wedde M; Birkner P; Schweiger B
    Antiviral Res; 2011 Jan; 89(1):115-8. PubMed ID: 21070812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.